Operating Income (Loss) of BIO-RAD LABORATORIES, INC. from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BIO-RAD LABORATORIES, INC. quarterly and annual Operating Income (Loss) in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • BIO-RAD LABORATORIES, INC. Operating Income (Loss) for the quarter ending 31 Dec 2025 was $118,900,000, a 304% decline year-over-year.
  • BIO-RAD LABORATORIES, INC. Operating Income (Loss) for the twelve months ending 31 Dec 2025 was $47,200,000, a 82% decline year-over-year.
  • BIO-RAD LABORATORIES, INC. annual Operating Income (Loss) for 2025 was $47,200,000, a 82% decline from 2024.
  • BIO-RAD LABORATORIES, INC. annual Operating Income (Loss) for 2024 was $269,000,000, a 20% decline from 2023.
  • BIO-RAD LABORATORIES, INC. annual Operating Income (Loss) for 2023 was $337,800,000, a 30% decline from 2022.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $47,200,000 $118,900,000 -$177,300,000 -304% 01 Oct 2025 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q3 2025 $224,500,000 $65,300,000 +$800,000 +1.2% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $223,700,000 $77,100,000 -$24,400,000 -24% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $248,100,000 $23,700,000 -$20,900,000 -47% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $269,000,000 $58,400,000 -$36,921,000 -39% 01 Oct 2024 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q3 2024 $305,921,000 $64,500,000 -$26,449,000 -29% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025 2025 Q3
Q2 2024 $332,370,000 $101,500,000 +$11,883,000 +13% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025 2025 Q2
Q1 2024 $320,487,000 $44,600,000 -$17,313,000 -28% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $337,800,000 $95,321,000 -$23,333,000 -20% 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2026 2025 FY
Q3 2023 $361,133,000 $90,949,000 -$3,697,000 -3.9% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 $364,830,000 $89,617,000 -$33,275,000 -27% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 $398,105,000 $61,913,000 -$84,495,000 -58% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $482,600,000 $118,654,000 +$766,000 +0.65% 01 Oct 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
Q3 2022 $481,834,000 $94,646,000 -$62,158,000 -40% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023 2023 Q3
Q2 2022 $543,992,000 $122,892,000 -$1,890,000 -1.5% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023 2023 Q2
Q1 2022 $545,882,000 $146,408,000 +$45,546,000 +45% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 $500,336,000 $117,888,000 -$67,723,000 -36% 01 Oct 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
Q3 2021 $568,059,000 $156,804,000 +$47,204,000 +43% 01 Jul 2021 30 Sep 2021 10-Q 28 Oct 2022 2022 Q3
Q2 2021 $520,855,000 $124,782,000 +$73,040,000 +141% 01 Apr 2021 30 Jun 2021 10-Q 29 Jul 2022 2022 Q2
Q1 2021 $447,815,000 $100,862,000 +$26,489,000 +36% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022 2022 Q1
Q4 2020 $421,326,000 $185,611,000 +$126,406,000 +214% 01 Oct 2020 31 Dec 2020 10-K 17 Feb 2023 2022 FY
Q3 2020 $294,920,000 $109,600,000 +$52,140,000 +91% 01 Jul 2020 30 Sep 2020 10-Q 29 Oct 2021 2021 Q3
Q2 2020 $242,780,000 $51,742,000 -$4,648,000 -8.2% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 $247,428,000 $74,373,000 +$17,767,000 +31% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q4 2019 $229,661,000 $59,205,000 +$286,259,000 01 Oct 2019 31 Dec 2019 10-K 11 Feb 2022 2021 FY
Q3 2019 $56,598,000 $57,460,000 +$21,185,000 +58% 01 Jul 2019 30 Sep 2019 10-Q 30 Oct 2020 2020 Q3
Q2 2019 $77,783,000 $56,390,000 +$12,598,000 +29% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2
Q1 2019 $90,381,000 $56,606,000 +$12,960,000 +30% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $103,341,000 $227,054,000 -$272,954,000 -595% 01 Oct 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
Q3 2018 $169,613,000 $36,275,000 -$2,487,000 -6.4% 01 Jul 2018 30 Sep 2018 10-Q 01 Nov 2019 2019 Q3
Q2 2018 $172,100,000 $43,792,000 +$45,493,000 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q1 2018 $126,607,000 $43,646,000 +$17,437,000 +67% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q4 2017 $109,170,000 $45,900,000 +$74,100,000 01 Oct 2017 31 Dec 2017 10-K 16 Apr 2018 2017 FY
Q3 2017 $35,070,000 $38,762,000 +$16,062,000 +71% 01 Jul 2017 30 Sep 2017 10-Q 05 Nov 2018 2018 Q3
Q2 2017 $19,008,000 $1,701,000 -$28,601,000 -106% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $47,609,000 $26,209,000 +$6,009,000 +30% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $41,600,000 $28,200,000 -$87,683,000 -147% 01 Oct 2016 31 Dec 2016 10-K 16 Apr 2018 2017 FY
Q3 2016 $129,283,000 $22,700,000 -$9,971,000 -31% 01 Jul 2016 30 Sep 2016 10-K 16 Apr 2018 2017 FY
Q2 2016 $139,254,000 $26,900,000 -$13,305,000 -33% 01 Apr 2016 30 Jun 2016 10-K 16 Apr 2018 2017 FY
Q1 2016 $152,559,000 $20,200,000 -$14,149,000 -41% 01 Jan 2016 31 Mar 2016 10-K 16 Apr 2018 2017 FY
Q4 2015 $166,708,000 $59,483,000 +$8,897,000 +18% 01 Oct 2015 31 Dec 2015 10-K 16 Apr 2018 2017 FY
Q3 2015 $157,811,000 $32,671,000 -$569,000 -1.7% 01 Jul 2015 30 Sep 2015 10-Q 02 Nov 2016 2016 Q3
Q2 2015 $158,380,000 $40,205,000 -$5,482,000 -12% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016 2016 Q2
Q1 2015 $163,862,000 $34,349,000 +$13,878,000 +68% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
Q4 2014 $149,984,000 $50,586,000 -$1,731,000 -3.3% 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $151,715,000 $33,240,000 +$4,182,000 +14% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2015 Q3
Q2 2014 $147,533,000 $45,687,000 -$7,242,000 -14% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 $154,775,000 $20,471,000 -$14,681,000 -42% 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015 2015 Q1
Q4 2013 $169,456,000 $52,317,000 -$18,344,000 -26% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
Q3 2013 $187,800,000 $29,058,000 -$36,783,000 -56% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2014 Q3
Q2 2013 $224,583,000 $52,929,000 -$20,379,000 -28% 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014 2014 Q2
Q1 2013 $244,962,000 $35,152,000 -$19,214,000 -35% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q4 2012 $264,176,000 $70,661,000 -$25,354,000 -26% 01 Oct 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
Q3 2012 $289,530,000 $65,841,000 -$8,081,000 -11% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2013 Q3
Q2 2012 $297,611,000 $73,308,000 +$5,122,000 +7.5% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013 2013 Q2
Q1 2012 $292,489,000 $54,366,000 -$12,752,000 -19% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q4 2011 $305,241,000 $96,015,000 +$18,231,000 +23% 01 Oct 2011 31 Dec 2011 10-K 18 Mar 2014 2013 FY
Q3 2011 $287,010,000 $73,922,000 -$880,000 -1.2% 01 Jul 2011 30 Sep 2011 10-Q 08 Nov 2012 2012 Q3
Q2 2011 $287,890,000 $68,186,000 +$10,000 +0.02% 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012 2012 Q2
Q1 2011 $287,880,000 $67,118,000 +$3,871,000 +6.1% 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q1
Q4 2010 $284,009,000 $77,784,000 01 Oct 2010 31 Dec 2010 10-K 18 Mar 2013 2012 FY
Q3 2010 $74,802,000 01 Jul 2010 30 Sep 2010 10-Q 03 Nov 2011 2011 Q3
Q2 2010 $68,176,000 01 Apr 2010 30 Jun 2010 10-Q 04 Aug 2011 2011 Q2
Q1 2010 $63,247,000 01 Jan 2010 31 Mar 2010 10-Q 06 May 2011 2011 Q1

BIO-RAD LABORATORIES, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $47,200,000 -$221,800,000 -82% 01 Jan 2025 31 Dec 2025 10-K 13 Feb 2026 2025 FY
2024 $269,000,000 -$68,800,000 -20% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2026 2025 FY
2023 $337,800,000 -$144,800,000 -30% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2026 2025 FY
2022 $482,600,000 -$17,736,000 -3.5% 01 Jan 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
2021 $500,336,000 +$79,010,000 +19% 01 Jan 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
2020 $421,326,000 +$191,665,000 +83% 01 Jan 2020 31 Dec 2020 10-K 17 Feb 2023 2022 FY
2019 $229,661,000 +$333,002,000 01 Jan 2019 31 Dec 2019 10-K 11 Feb 2022 2021 FY
2018 $103,341,000 -$222,591,000 -187% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
2017 $119,250,000 +$63,532,000 +114% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $55,718,000 -$110,990,000 -67% 01 Jan 2016 31 Dec 2016 10-K 01 Apr 2019 2018 FY
2015 $166,708,000 +$16,724,000 +11% 01 Jan 2015 31 Dec 2015 10-K 16 Apr 2018 2017 FY
2014 $149,984,000 -$19,472,000 -11% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $169,456,000 -$94,720,000 -36% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $264,176,000 -$41,065,000 -13% 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
2011 $305,241,000 +$21,232,000 +7.5% 01 Jan 2011 31 Dec 2011 10-K 18 Mar 2014 2013 FY
2010 $284,009,000 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.